Skip to main content

Author: Customer Service

L5 Networks Joins Volaris Group

TORONTO, Aug. 24, 2026 (GLOBE NEWSWIRE) — Volaris Group today announced the acquisition of L5 Networks, a Brazilian pioneer in cloud-based corporate communications solutions and one of the country’s leading omnichannel and corporate collaboration platforms. Since its founding in 2005 and throughout more than 20 years of history, L5 Networks has been driven by the purpose of delivering comprehensive cloud-based corporate communications solutions. The company was the first to make Cloud PBX available in Brazil as a SaaS offering. Today, L5 Networks serves more than 1,000 active customers and hundreds of thousands of users across eight major industry segments, offering a broad portfolio of technology, communication, and collaboration solutions. Its offering addresses a wide range of organizational needs, including communications, customer...

Continue reading

Lexis+ with Protégé Accelerates Frictionless Agentic Productivity from First Idea to Review-Ready Legal Work Product

Expanded capabilities bring together LexisNexis authoritative intelligence, agents, skills, workflows, and AI models in one intuitive experience so legal professionals can accomplish more with AI NEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) — LexisNexis® Legal & Professional today unveiled new agentic capabilities in Lexis+® with Protégé™, enabling legal professionals to move from first idea to review-ready work product in one intuitive AI experience. Legal professionals simply describe what they want to accomplish, and Lexis+ with Protégé applies the right AI models – including LexisNexis models that build on years of model optimization expertise – along with appropriate agents, skills, and selected sources behind the scenes. It carries context forward from early exploration and strategy through research, analysis, drafting,...

Continue reading

ATIS Acquires AuditMate to Advance a Next-Generation Approach to Elevator Management

ST. LOUIS, Aug. 24, 2026 (GLOBE NEWSWIRE) — ATIS, a leading provider of elevator and escalator inspections, consulting, and managed services, today announced the acquisition of AuditMate, the leading elevator auditing and management technology platform. Building owners and property managers have long operated with limited visibility into how their elevators are performing and maintained. ATIS has helped address that challenge through its inspections, consulting, and managed services. The addition of AuditMate builds on that foundation, adding greater transparency, speed, and depth to how portfolios are managed. By integrating AuditMate’s technology platform with ATIS’ consulting, inspections and managed services expertise, ATIS is creating a next-generation approach to elevator management. Clients gain greater visibility into maintenance...

Continue reading

New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026

DUBLIN and BRIDGEWATER, N.J., Aug. 24, 2026 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2026, August 28th – 31st, in Munich, Germany. The accepted abstracts add to the body of evidence generated from REDUCE-IT and related research investigating cardiovascular risk factors, biomarkers and potential mechanisms associated with the effects of icosapent ethyl or eicosapentaenoic acid (EPA). The presentations include analyses of treatment adherence, long-term outcomes, lipoprotein(a) [Lp(a)], coagulation biomarkers and cellular pathways relevant to cardiovascular disease. Featured Amarin-supported abstracts to be presented by international academic...

Continue reading

Edible Garden and Square Roots Announce Strategic Partnership to Accelerate Farm-to-Formula® Functional Nutrition Platform

Collaboration Combines Agricultural Innovation, Plant Science and Commercial Manufacturing to Develop Next-Generation Clean-Label Functional Beverages BELVIDERE, NJ, Aug. 24, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, better-for-you, sustainable produce and products, and Square Roots, an agricultural innovation company founded on the belief that controlled-environment agriculture could empower a new generation of farmers while using technology to produce fresher, locally grown food with enhanced taste and nutritional attributes, today announced a strategic product development partnership to develop a new generation of clean-label, functional ready-to-drink (“RTD”) beverages....

Continue reading

NexBoard™ Positions Itself as a Universal Construction Panel Capable of Replacing Multiple Traditional Building Materials

Independent Testing Shows Superior Resistance and Strength Across Key Performance Standards, Enabling One Panel for Interior, Exterior, and Semi-Structural Applications BOCA RATON, Fla., Aug. 24, 2026 (GLOBE NEWSWIRE) — Xeriant, Inc. (OTCQB: XERI), a company dedicated to the discovery, development, and commercialization of transformative technologies, today highlighted the potential of its NexBoard composite panel to serve as a true universal construction board. Independent laboratory testing demonstrates that NexBoard outperforms conventional drywall, magnesium oxide (MgO) board, oriented strand board (OSB), medium-density fiberboard (MDF), and plywood across critical performance categories, positioning it as a single material solution for multiple applications that traditionally require several different products. The implications...

Continue reading

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

LEQEMBI IQLIK is the first-of-its-kind anti-amyloid treatment worldwide offering at-home dosing for initiation and maintenance (approved in the U.S.) TOKYO and CAMBRIDGE, Mass., Aug. 24, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced today that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in the U.S. for initiation therapy for early Alzheimer’s disease (AD) in adults with mild cognitive impairment (MCI) or mild dementia due to AD, collectively referred to as early AD. MCI due to AD is the earliest symptomatic stage of AD and can appear with subtle symptoms such as forgetfulness, confusion, or feeling at a loss for words.1 LEQEMBI IQLIK is administered via an autoinjector, introducing a convenient alternative to intravenous (IV) dosing from the...

Continue reading

Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

U.S. publication of the patent application covering the MDMA-N-acylethanolamines combination expands intellectual property generated through the collaboration with Neurothera Labs Inc. as the FDA  introduces a dedicated regulatory structure for psychedelic drug development, including MDMA Vancouver, Canada, Aug. 24, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biopharmaceutical  company   advancing non-hallucinogenic, psychedelic-derived neuroplastogens  for scalable treatment  of neuropsychiatric, metabolic, and addiction disorders, including AUD,  today announced  an advancement of its IP portfolio with the publication in the United States of its patent application covering a novel combination of 3,4-methylenedioxymethamphetamine (“MDMA”) and N-acylethanolamines, such as palmitoylethanolamide...

Continue reading

Kaldvik AS (KLDVK): Invitation to Q2 2026 Results Webcast

A presentation of Kaldvik AS Q2 2026 results will be held at 10:00 CEST / 08:00 UTC on 27 August 2026. CEO Vidar Aspehaug and CFO Þórunn Ragnarsdóttir will present the Company’s results. The session will be held online in English. A Q&A session will follow the presentation. The webcast can be accessed via the following link: www.kaldvik.is/live The Q2 2026 results, together with the Half-Year 2026 report, will be published on 27 August 2026 at 07:00 CEST. Contacts:Vidar Aspehaug, CEO+47 913 05 017 (mobile) Þórunn Ragnarsdóttir, CFO+354 822 7649 (mobile) This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Continue reading

AGF Investments Announces August 2026 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Enhanced U.S. Income Plus Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure ETF

TORONTO, Aug. 24, 2026 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments)  (TSX:AGF.B) today announced the August 2026 cash distributions for AGF Enhanced U.S. Equity Income Fund*, AGF Enhanced U.S. Income Plus Fund*, AGF Total Return Bond Fund* and AGF Systematic Global Infrastructure ETF, which pay monthly distributions. Unitholders of record on August 31, 2026 will receive cash distributions payable on September 4, 2026. Details regarding the final “per unit” distribution amounts are as follows:ETF Ticker Exchange Cash Distribution Per Unit ($)AGF Enhanced U.S. Equity Income Fund* AENU Cboe Canada Inc. $0.201070AGF Enhanced U.S. Income Plus Fund* AENP Toronto Stock Exchange $0.209168AGF Total Return Bond Fund* ATRB Cboe Canada Inc. $0.103000AGF Systematic Global Infrastructure ETF QIF Cboe Canada Inc. $0.167513*AGF...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.